Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e76e822c-fad7-49e0-970c-47926843db34
Date 1/12/2016
Company Name Ancera
Mailing Address 21 Business Park Drive Branford, CT 06405 USA
Company Description The company is developing a rapid, portable technology platform for the separation, quantitative detection and identification of minute concentrations of various pathogens from whole blood or other bodily fluids. Ancera’s platform is based on technology it is licensing exclusively from Yale University.
Proceeds Purposes Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.